Question 41 : Which of the following prostate cancers produce more PSA per gram :
a) Poorly differentiated
b) well differentiated
Answer : well differentiated
Question 42 : PSA is misleading many times in the screening and diagnosis of prostate cancer. Which of the following markers are available at present for aiding in the diagnosis :
a) 4Kscore test
b) Prostate Health Index (PHI)
c) Both of the above
d) Neither 1 nor 2
Answer : Both of the above
Question 43 : Urinary PCA-3 has been approved by the FDA to determine the likelihood of cancer in men with an elevated PSA level and a previously negative biopsy :
a) True
b) False
Answer : True
Question 44 : Which of the following is the preferred imaging modality for identifying suspicious lesions for guided biopsies of prostate :
a) MRI
b) TRUS
c) CT scan
d) Integrated PET-CT scan
Answer : MRI
Question 45 : Which of the following imaging is recommended in patients with clinically localized prostate cancer having Gleason 7, PSA of 10 ng/mL:
a) CT scan
b) Bone scan
c) Both of the above
d) Neither 1 nor 2
Answer : Neither 1 nor 2
Question 46 : Partin tables are used in cases of prostate cancer to predict what :
a) Prognosis after surgery
b) Prognosis after radiation
c) Pathologic stage
d) Life expectancy
Answer : Pathologic stage
Question 47 : Which of the following classification is most commonly used to ascribe risk groups to cases of prostate cancer :
a) D’Amico classification
b) Partin nomogram
c) Church-Bethlehem score
d) Adjusted Huit class
Answer : D’Amico classification
Question 48 : In the Protec T trial, which compared active monitoring , RP, and EBRT for the treatment of clinically localized prostate, which of the following treatment strategy resulted in better survival outcomes :
a) RP
b) AS
c) RT
d) None of the above
Answer : none of the above
Question 49 : Which of the following tests are used in AS of prostate cancer patients :
a) DRE every 6 months
b) PSA every 6 months
c) Imagining and biopsy every 2 to 3 years
d) All of the above
Answer : all of the above
Question 50 : Which of the following is false about lymph node metastasis in prostate cancer :
a) Low-risk patients have nodal mets in 0.5% to 2% cases
b) Intermediate-risk prostate cancer patients have lymph node mets in 5% to 20% of cases
c) In high-risk cancer patients, the rates of LN mets are 20% to 50%
d) Prophylactic LN dissection (PLND) is recommended in patients having > 10% probability of LN mets
Answer : Prophylactic LN dissection (PLND) is recommended in patients having > 10% probability of LN mets